Form 4: Quest Diagnostics Director Acquires Additional Shares Through Dividend Reinvestment
SEC Form 4
Vicky B. Gregg, a director at Quest Diagnostics, increased her holdings through a dividend reinvestment plan.
Summary
- On April 22, 2024, Vicky B. Gregg, a director of Quest Diagnostics Inc. (DGX), acquired 81 shares of common stock at a price of $126.244 per share.
- The acquisition was made through a dividend reinvestment plan.
- Following the transaction, Gregg directly owns 16,410 shares of Quest Diagnostics.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's participation in the dividend reinvestment plan suggests confidence, but the transaction is routine.
Positives
- The director's participation in the dividend reinvestment plan signals confidence in the company's future.
Industry Context
Dividend reinvestment plans are a common way for investors, including company insiders, to increase their holdings in a company. It reflects a long-term investment strategy.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine purchase of shares by a director.
Key Dates
| Date | Description |
|---|---|
| 04/22/2024 | Date of transaction: Vicky B. Gregg acquired 81 shares of Quest Diagnostics common stock. |
| 04/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.